Miglustat
Miglustat is an alkylated derivative of deoxynojirimycin, functioning as a glucosylceramide synthase inhibitor. It is primarily used in research related to Type 1 Gaucher disease, with applications in both in vitro enzymatic studies and in vivo animal models of lysosomal storage disorders.
Product Specifications
CAS Number
72599-27-0
Product Name Alternative
Type I gaucher disease, ceramide glucosyltransferase, Inhibitor, inhibit, oral, OGT 918, OGT918, OGT-918, NB-DNJ, N-Butyldeoxynojirimycin, Miglustat
Field of Research
Metabolism Research, Pharmacology & Drug Discovery
Purity
99.75% (May vary between batches)
Solubility
DMSO:130 mg/mL (592.85 mM)
Smiles
CCCCN1C[C@@H] ([C@H] ([C@@H] ([C@H]1CO) O) O) O
Molecular Formula
C10H21NO4
Molecular Weight
219.28
Storage Conditions
-20°C
Notes
For research use only.
Available Sizes
Frequently Asked Questions
More Discoveries
Explore Other Products
Browse additional items from our catalog
MBS2049916-01 0.1 mL
APC/CY7-Linked Polyclonal Antibody to Cluster Of Differentiation 6 (CD6)
Sign In for Pricing
View Details MBS2049916-02 0.2 mL
APC/CY7-Linked Polyclonal Antibody to Cluster Of Differentiation 6 (CD6)
Sign In for Pricing
View Details MBS2049916-03 0.5 mL
APC/CY7-Linked Polyclonal Antibody to Cluster Of Differentiation 6 (CD6)
Sign In for Pricing
View Details MBS2049916-04 1 mL
APC/CY7-Linked Polyclonal Antibody to Cluster Of Differentiation 6 (CD6)
Sign In for Pricing
View Details